Register now! Only 25 spaces available!
Please log in for MITCNC Member pricing
$30 MITCNC members, $40 nonmembers
Join the club! Buy your membership HERE (MIT alums only)
Come tour RefleXion Medical, which has developed technology to identify and treats cancer without need for biopsies. RefleXion combines PET imaging and radiotherapy in a single machine, which leverages real-time imaging of cancer cells by their metabolic activity. This approach enables detection, analysis, and killing of multiple tumors in a single treatment.
RefleXion was co-founded by Samuel Mazin and MIT alumnus Akshay Nanduri (MBA ’09). They have received $63 million in funding from investors that include Johnson & Johnson Innovation, Sofinnova Partners and Pfizer Venture Investments and were also participated in MITCNC’s Venture Mentoring Service (VMS Bay Area).
For more information, please contact Zeenat Patrawala: email@example.com